1Yarbro C H, Frogge M H, Goodman M. Cancer Symptom Management[M]. 3rd. Burlington :Jones and Bartlett Learning, Inc,2004.
2Cleeland C S. Symptom Burden: Muhiple Symptoms and Their Impact As Patient-reported Outcomes[ J ]. J Natl Can- cer Inst Monogr, 2007(37):16-21.
3Gapstur R L. Symptom Burden: A Concept Analysis and Im- plications for Oncology Nurses[ J ]. Oncol Nurs Forum, 2007, 34(3):673-680.
4Fan G, Filipczak L, Chow E. Symptom Clusters in Cancer Patients:a Review of the Literature[ J ]. Curr Oncol, 2007, 14 (5):173-179.
5Miaskowski C, Dodd M, Lee K. Symptom Clusters: the New Frontier in Symptom Management Research[ J ]. J Natl Can- cer Inst Monogr, 2004(32):17-21.
6Fu M R, McDaniel R W, Rhodes V A. Measuring Symptom Occurrence and Symptom Distress: Development of the Symptom Experience Index[ J ]. J Adv Nurs, 2007, 59(6): 623-634.
7Yost K J, Yount S E, Eton D T, et al. Validation of the Functional Assessment of Cancer Therapy-Breast Symptom Index (FBSI)[ J ]. Breast Cancer Res Treat, 2005, 90(3):295- 298.
8Hollen P J, Gralla R J, Liepa A M, et al. Adapting the Lung Cancer Symptom Scale (LCSS) to Mesothelioma: Using the LCSS-Meso Conceptual Model for Validation[ J ]. Cancer, 2004, 101(3):587-595.
9Rao D, Butt Z, Rosenbloom S, et al. A Comparison of the Renal Cell Carcinoma-Symptom Index (RCC-SI) and the Functional Assessment of Cancer Therapy-Kidney Symp- tom Index (FKSI)[ J ]. J Pain Symptom Manage, 2009, 38 (2):291-298.
10Koensgen D, Oskay-Oezcelik G, Katsares I, et al. Develop- ment of the Berlin Symptom Checklist Ovary (BSCL-O) for the Measurement of Quality of Life of Patients with Primary and Recurrent Ovarian Cancer: Results of a Phase I and II Study[ J ]. Support Care Cancer, 2010, 18(8):931-942.
